Abstract
A randomised control multicentre study to compare the safety and efficacy of albendazole and metronidazole in the treatment of giardiasis in children is reported. One hundred and fifty children of either sex (age range: 2–10 years) were randomised to receive either a single dose of 400 mg of albendazole suspension, or 22.5 mg/kg/day of metronidazole in 3 divided doses for 5 consecutive days. At the end of therapy, majority of children in both treatment groups were symptom free. Two days after completion of therapy, 97% of children in both treatment groups were giardia free in the stools. Side effects were noted in 3 children in the albendazole group, and in 20 children in the metronidazole group. We conclude that albendazole suspension is as effective as metronidazole in the treatment of giardial infection in children. It is safe and has fewer side effects as compared to metronidazole.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Refrences
Rossignol JF, Masionneuve F. Albendazole: A new concept in the control of helminthiasis.Gastroenterol Clin Biol 1984; 8: 569–576.
Jagota SC. Albendazole, a broad spectrum anthelmintic in the treatment of intestinal nematode and cestode infection. A multicentre study in 480 patients.Clin Ther 1986; 83: 97–102.
Gil-Grande LA, Rodriguez-Cabeiro F, Prieto JG et al. Randomised controlled trial of efficacy of albendazole in intraabdominal hydatid disease.Lancet 1993; 342: 1269–1272.
Alarcon F, Esclarite L, Duenas G et al. Neurocysticercosis. Short course treatment with albendazole.Arch Neurol 1989; 46: 1231–1236.
Meloni BP, Thompson RCA, Reynoldson JA, Seville P. Albendazole: A more effective antigiardial agent in vitro than metronidazole or tinidazole.Trans Roy Soc Trop Med & Hyg 1990; 84: 375–379.
Reynoldson JA, Thompson RCA, Meloni BP. The potential and possible mode of action of benzimidazoles against Giardia and other protozoa.J Pharm Med 1992; 2: 35–50.
Hall A, Nahar Q. Albendazole as a treatment for infection with G. Dyodenalis in children in Bangladesh.Trans Roy Soc Trop Med & Hyg 1983; 87: 84–86.
Fisher RA, Yates F,Statistical Tables for Biological, Agricultural and Medical Research, 6th ed. London: Longman, 1975.
Antia FP, Desai HG, Jeejeebhoy KN et al. Giardiasis in adults-incidence, symptomatology and absorption studies.Indian J Med Sci 1966; 20: 471–477.
Kapoor SC, Mody GD. Clinical features of Giardiasis.J Assoc Physcicians Ind 1968; 16: 431–433.
Wright SG, Tomkins AM, Ridley DS. Giardiasis: Clinical and therapeutic aspects.Gut 1977; 18: 343–350.
James DM, Giles HM.Human Antiparasitic Drugs: Pharmacology and Usage. Chichester: John Wiley, 1985.
Edlind TD, Hang TL, Chakraborty PR. Activity of anthelmintic benzimidazoles againstGiardia lamblia in vitro.J Infect Dis 1990; 162: 1408–1411.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dutta, A.K., Phadke, M.A., Bagade, A.C. et al. A randomised multicentre study to compare the safety and efficacy of albendazole and metronidazole in the treatment of giardiasis in children. Indian J Pediatr 61, 689–693 (1994). https://doi.org/10.1007/BF02751980
Issue Date:
DOI: https://doi.org/10.1007/BF02751980